PAR-22-250 - Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Supporting Data Sciences Research in IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase 1 Program | NOT-GM-23-011 | NIGMS, ODSS | Oct 31, 2022 | Jan 31, 2025 | P20 |
| Notice of Special Interest (NOSI): Supporting Womens Health Research in IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase 1 Program | NOT-GM-23-012 | NIGMS, ORWH | Oct 27, 2022 | Jan 31, 2025 | P20 |
For technical issues E-mail OER Webmaster